fbpx
Friday, April 23, 2021
No menu items!

U.S. authorizes Johnson & Johnson’s COVID-19 vaccine

The U.S. government on Saturday (February 27) authorized Johnson & Johnson’s single-dose COVID-19 vaccine, enabling millions more Americans to be vaccinated in the coming weeks and setting it up for additional approvals around the world.

The U.S. Food and Drug Administration announced the emergency use authorization for adults aged 18 and older following Friday’s unanimous endorsement by the agency’s panel of outside experts.

“The authorization of this vaccine expands the availability of vaccines, the best medical prevention method for COVID-19, to help us in the fight against this pandemic, which has claimed over half a million lives in the United States,” Acting FDA Commissioner Janet Woodcock said in a statement.

In J&J’s 44,000-person global trial, the vaccine was found to be 66% effective at preventing moderate-to-severe COVID-19 four weeks after inoculation, and 100% effective in preventing hospitalization and death due to the virus.

There were very few serious side effects reported in the trial, which also offered some preliminary evidence that the vaccine reduced asymptomatic infections.

However, more study is expected, and the FDA on Sunday dismissed the idea that evidence proved the vaccine prevented transmission between people and added there was no data to determine how long the vaccine’s protection lasted.

J&J’s vaccine is expected to be used widely around the globe because it can be shipped and stored at normal refrigerator temperatures, making distribution easier than for the Pfizer Inc /BioNTech SE and Moderna Inc vaccines, which are shipped frozen.

The U.S. government, which has purchased 100 million doses of the J&J vaccine, plans to distribute about 3 million to 4 million this week. That would be on top of the around 16 million doses of the Pfizer/BioNTech and Moderna vaccines it already planned to ship across the country.

J&J plans to provide a total of 20 million doses by the end of March, which along with the more than 220 million total doses expected from Pfizer and Moderna would be enough to fully vaccinate 130 million people in the United States.

So far, the United States has distributed more than 90 million doses of COVID-19 vaccines, some of which have been used for second shots. About 14% of Americans have received at least one dose, according to U.S. government data.

COVID-19 has claimed more than half a million lives in the United States and states are clamoring for more doses to stem cases, hospitalizations, and deaths.

(Production: Kia Johnson)

Advertisement

Latest News

Two brothers died after crane ‘malfunctions’ on I-10 near Smith Road in Jefferson Co.

A 2013 Toyota pickup truck was traveling westbound on I-10 near Smith Road around 4:30 p.m. Thursday.Troopers...

U.S. stocks drop on news of Biden tax proposals

U.S. stocks dived on Thursday (April 22) on reports President Joe Biden planned to almost double the capital gains tax, news analysts...

U.S. House passes bill to make Washington, D.C., the 51st state

The U.S. House of Representatives on Thursday (April 22) narrowly voted, for the second time in less than a year, to make...

Singer Ali Haider is back in action with a new show

'Purani Jeans' singer Ali Haider is ready to try on new jeans, hosting a show called The Ali Haider Show for NTV Houston, USA.

U.S. pledges to halve its emissions by 2030 as Biden opens climate summit

The Biden administration on Thursday (April 22) pledged to slash U.S. greenhouse gas emissions by 50%-52% from 2005 levels by 2030, a...

More Articles Like This